ERLOTINIB for Hypertension: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 15 adverse event reports in the FDA FAERS database where ERLOTINIB was used for Hypertension.
Most Reported Side Effects for ERLOTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 5,000 | 22.3% | 4,996 | 386 |
| Rash | 4,648 | 20.7% | 580 | 485 |
| Diarrhoea | 3,448 | 15.3% | 462 | 598 |
| Fatigue | 1,548 | 6.9% | 392 | 246 |
| Nausea | 1,366 | 6.1% | 284 | 290 |
| Drug ineffective | 1,207 | 5.4% | 159 | 101 |
| Off label use | 1,190 | 5.3% | 809 | 198 |
| Decreased appetite | 998 | 4.4% | 249 | 234 |
| Malignant neoplasm progression | 954 | 4.3% | 494 | 230 |
| Dry skin | 953 | 4.2% | 57 | 83 |
| Disease progression | 910 | 4.1% | 246 | 93 |
| Pruritus | 830 | 3.7% | 68 | 82 |
| Vomiting | 820 | 3.7% | 199 | 271 |
| Asthenia | 757 | 3.4% | 281 | 230 |
| Dyspnoea | 738 | 3.3% | 265 | 283 |
Other Indications for ERLOTINIB
Lung neoplasm malignant (9,207)
Non-small cell lung cancer (3,359)
Product used for unknown indication (3,040)
Pancreatic carcinoma (1,089)
Malignant respiratory tract neoplasm (876)
Lung adenocarcinoma (841)
Neoplasm malignant (565)
Bronchial carcinoma (397)
Non-small cell lung cancer metastatic (290)
Lung adenocarcinoma stage iv (203)
Other Drugs Used for Hypertension
AMLODIPINE (20,207)
LISINOPRIL (11,824)
RAMIPRIL (10,210)
VALSARTAN (8,956)
LOSARTAN (7,966)
FUROSEMIDE (7,490)
HYDROCHLOROTHIAZIDE (7,119)
METOPROLOL (5,918)
OLMESARTAN MEDOXOMIL (5,702)
BISOPROLOL (5,520)